Anteotech logo
ADO
Pharmaceuticals, Biotechnology & Life Sciences

Anteotech

Short interest
0.00%
−0.03 pp 30d
as of 9 Oct 2026
Reported shorts
1.3K
Shares on issue
3.265B

Anteotech (ADO) News

Latest articles and price-sensitive announcements with AI sentiment classification.

Kalkine
Neutral
28 Sept

Does AnteoTech (ASX:ADO) Have Commercial Traction in Anodes?

Highlights AnteoTech has signed a strategic sales agreement and launched new products in its battery materials division. Independent validation of its silicon anode formulation has strengthened its technical credentials. The micro-cap still trades at a fraction of a dollar as the market waits for revenue to follow. AnteoTech (ASX:ADO) lodged an update to its preliminary final report this month, capping a busy stretch in which the micro-cap signed a strategic collaboration and sales agreement ...

Kalkine
Neutral
23 Sept

Could ADO (ASX:ADO) Spark Fresh ASX Interest After Its Latest Results Webinar Update?

Highlights ADO has a fresh same-day disclosure focused on the Results Webinar. The article places the event within the ASX Technology Stocks category without forcing a broader claim. The copy separates confirmed information from later outcomes that still need company evidence. Reporting releases give a structured view of revenue, earnings, cash flow and outlook. ADO (ASX:ADO) is in focus after a same-day update centred on the Results Webinar. The development gives Australian readers following...

Kalkine
Neutral
9 Sept

AnteoTech Clarifies Technology Delivery (ASX:ADO)

Highlights AnteoTech has placed technology delivery at the centre of current exchange interest through its recent filing. The update directs attention toward customer adoption, recurring revenue and service reliability without removing the need for careful evidence review. Market reading depends on delivery quality, clear reporting and alignment between strategy, funding and operating conditions. AnteoTech (ASX:ADO) has drawn attention during the latest completed Australian market session aft...

Kalkine
Neutral
9 Sept

AnteoTech Clarifies Delivery Pathway (ASX:ADO)

Highlights AnteoTech has placed delivery pathway at the centre of current equity attention through its current notice. The update directs attention toward funding runway, milestone delivery and market liquidity without removing the need for careful evidence review. Exchange assessment depends on delivery quality, clear reporting and alignment between strategy, funding and operating conditions. AnteoTech (ASX:ADO) has drawn attention during the latest completed Australian market session after ...